Back to Search
REED FREIDINGER, M.D.
M.D.
Internal Medicine Physician
NPI: 1780678680Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301031046(MI)
Research & Publications (20)
Design and synthesis of novel bioactive peptides and peptidomimetics.
PMID 14667208·J Med Chem·2003
7-preclinical
Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.
PMID 19648007·Bioorg Med Chem Lett·2009
8-other
2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
PMID 18553956·J Med Chem·2008
7-preclinical
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
PMID 18061443·Bioorg Med Chem Lett·2008
7-preclinical
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
PMID 17428657·Bioorg Med Chem Lett·2007
7-preclinical
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
PMID 16480259·J Med Chem·2006
7-preclinical
Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
PMID 15993596·Bioorg Med Chem Lett·2005
7-preclinical
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
PMID 15845373·Biochem Biophys Res Commun·2005
8-other
2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.
PMID 15837330·Bioorg Med Chem Lett·2005
8-other
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.
PMID 15546726·Bioorg Med Chem Lett·2004
7-preclinical
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
PMID 15363953·Eur J Pharmacol·2004
7-preclinical
Progress towards the development of a HIV-1 gp41-directed vaccine.
PMID 15078183·Curr HIV Res·2004
6-review
NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
PMID 15056006·J Med Chem·2004
7-preclinical
Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
PMID 12812482·J Am Chem Soc·2003
7-preclinical
Benzodiazepines as potent and selective bradykinin B1 antagonists.
PMID 12723943·J Med Chem·2003
7-preclinical
Identification of a series of CCK-2 receptor nonpeptide agonists: sensitivity to stereochemistry and a receptor point mutation.
PMID 12697901·Proc Natl Acad Sci U S A·2003
7-preclinical
Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents.
PMID 12643935·Bioorg Med Chem Lett·2003
7-preclinical
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
PMID 12641452·Biochemistry·2003
8-other
Orally efficacious NR2B-selective NMDA receptor antagonists.
PMID 12639561·Bioorg Med Chem Lett·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14730 PARK AVE
CHARLEVOIX, MI 49720 - Phone
- (231) 547-4488
Quick Facts
- NPI
- 1780678680
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile